NCT00002085View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Mycobacterium Avium-Intracellulare InfectionHIV InfectionsTuberculosis, Mycobacterium Infection
Interventions
DRUG

Azithromycin

Trial Locations (2)

20892

Natl Cancer Institute / Metabolism Branch, Bethesda

06340

Pfizer Central Research, Groton

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00002085 - A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy | Biotech Hunter | Biotech Hunter